Preliminary Q3 2025 Acquired IPRD & Licensing Income

Bristol-Myers Squibb Company published this content on October 03, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 03, 2025 at 20:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]